Health
Big trials push beyond obesity to see if GLP-1s can quell alcohol, drug cravings - Endpoints News

What the report says
Eli Lilly tests brenipatide for alcohol use disorder & depression; CASPR/UPMC trials Novo's Wegovy for addiction. GLP-1 drugs show promise beyond metabolic disorders.
Loading debate for this article…
Other publishers covering this story
No additional verified coverage is currently clustered with this report.

Lango Seeks Japanese Investment in Agriculture, Industry and Social ServicesNile Post
Medicine shortages undermining village health teamsThe Observer
Depression: Walking Through the Three Corners of Life Toward HealingNile Post
Ebola: Uganda Reinstates Traveller Locator FormsNile Post
Atwine Warns Border Officers Over Ebola Screening Lapses at MpondweNile Post